Recent advances in therapeutic gene-editing technologies
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Gene editing tools like CRISPR, base editors, and prime editors enable precise genetic changes. New tools like mobile genetic elements and epigenetic editors are advancing gene therapy development.
Area Of Science
- Biomedical Research
- Gene Therapy
- Molecular Biology
Background
- CRISPR gene editing has rapidly evolved, leading to precise nucleotide modification tools.
- New CRISPR-based systems and alternatives like mobile genetic elements (MGEs) and epigenetic editors are emerging.
- These innovations overcome limitations of earlier gene editing techniques, such as double-strand breaks (DSBs).
Purpose Of The Study
- To review recent advancements in genetic and epigenetic editing tools.
- To explore preclinical innovations in gene editing for therapeutic development.
- To highlight the potential of these tools for next-generation gene therapy.
Main Methods
- Review of recent scientific literature on gene editing technologies.
- Analysis of CRISPR-based systems, including base and prime editors.
- Exploration of alternative gene editing strategies like MGEs and epigenetic editors.
Main Results
- CRISPR technology has advanced to base and prime editors, allowing precise edits without double-strand breaks.
- CRISPR fusion systems and other tools expand capabilities for editing larger DNA sequences.
- Mobile genetic elements and epigenetic editors offer efficient alternatives for large insertions and stable gene manipulation.
Conclusions
- Recent gene editing tool developments, including CRISPR iterations and novel alternatives, are revolutionizing biomedical research.
- These advanced tools expand therapeutic possibilities and pave the way for next-generation gene therapies.
- Preclinical innovations in gene editing are poised to significantly advance the field of gene therapy.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
Overview
Genetic engineering is the process of modifying an organism’s DNA to introduce new, desirable traits. Many organisms, from bacteria to plants and animals, have been genetically modified for academic, medical, agricultural, and industrial purposes. While genetic engineering has definite benefits, ethical concerns surround modifying humans and our food supply.
Scientists can Deliberately Modify an Organism’s Genome
Genetic engineering is possible because the genetic...
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
The Process
Genes can be randomly knocked out, or specific genes can be targeted. To knock out a particular gene, an engineered piece of DNA called a targeting vector is used...
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...